These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2674072

  • 21. Donor-specific transfusions. Donor-recipient HLA compatibility, recipient HLA haplotype, and antibody production.
    Radvany RM, Patel KM.
    Transfusion; 1988; 28(2):137-41. PubMed ID: 3281335
    [Abstract] [Full Text] [Related]

  • 22. Soluble HLA and anti-idiotypic antibodies in transplantation: modulation of anti-HLA antibodies by soluble HLA antigens from the graft and anti-idiotypic antibodies in renal and cardiac allograft recipients.
    Suciu-Foca N, Ho E, King DW, Yu YP, Yu-Kai S, Reed E, Cohen D, Brensilver JM, McCabe R, Rose E.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):295-6. PubMed ID: 1990536
    [No Abstract] [Full Text] [Related]

  • 23. Anti-idiotypic antibodies from highly sensitized patients stimulate B cells to produce anti-HLA antibodies.
    Hack N, Angra S, Friedman E, McKnight T, Cardella CJ.
    Transplantation; 2002 Jun 27; 73(12):1853-8. PubMed ID: 12131677
    [Abstract] [Full Text] [Related]

  • 24. IgM anti-idiotypes that block anti-HLA antibodies: naturally occurring or immune antibodies?
    Urlacher A, Tongio MM, Pasquali JL.
    Clin Exp Immunol; 1991 Jan 27; 83(1):116-20. PubMed ID: 1703054
    [Abstract] [Full Text] [Related]

  • 25. Anti-idiotypic antibodies to HLA-DR4 and DR2.
    Reed E, Bonagura V, Kung P, King DW, Suciu-Foca N.
    J Immunol; 1983 Dec 27; 131(6):2890-4. PubMed ID: 6417234
    [Abstract] [Full Text] [Related]

  • 26. Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients.
    Reed E, Hardy M, Benvenisty A, Lattes C, Brensilver J, McCabe R, Reemstma K, King DW, Suciu-Foca N.
    N Engl J Med; 1987 Jun 04; 316(23):1450-5. PubMed ID: 3553951
    [Abstract] [Full Text] [Related]

  • 27. Antiidiotypic activity and sensitization after donor-specific transfusion (DST) given with and without cyclosporin A (CsA).
    Hillis AN, MacLeod AM, al-Muzairai IA, Innes A, Stewart KN, Power DA, Bone MJ, Sells RA, Catto GR.
    Transplant Proc; 1989 Feb 04; 21(1 Pt 2):1820-1. PubMed ID: 2652591
    [No Abstract] [Full Text] [Related]

  • 28. Detection of anti-idiotypic antibodies to HLA (anti-anti-HLA antibodies) by use of human monoclonal antibodies.
    Pistillo MP, Ferrara GB, Reed E, Brensilver J, McCabe R, Benvensity A, Hardy M, King DW, Suciu-Foca N.
    Transplant Proc; 1989 Feb 04; 21(1 Pt 1):760-1. PubMed ID: 2650260
    [No Abstract] [Full Text] [Related]

  • 29. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
    Itabashi Y, Aikawa A, Muramatsu M, Hyoudou Y, Shinoda K, Takahashi Y, Sakurabayashi K, Mizutani T, Oguchi H, Arai T, Kawamura T, Hamasaki Y, Sakai K, Shishido S.
    Exp Clin Transplant; 2019 Jan 04; 17(Suppl 1):43-49. PubMed ID: 30777522
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Anti-idiotypic antibodies to HLA and their influence on patient sensitization.
    Reed E, Hardy M, Brensilver J, Lattes C, McCabe R, D'gati V, Reemtsma K, Suciu-Foca N.
    Transplant Proc; 1987 Feb 04; 19(1 Pt 1):762-3. PubMed ID: 3274865
    [No Abstract] [Full Text] [Related]

  • 33. Association Between HLA Antibodies and Different Sensitization Events in Renal Transplant Candidates.
    Akgul SU, Ciftci HS, Temurhan S, Caliskan Y, Bayraktar A, Tefik T, Kaya IA, Canitez IO, Demir E, Yazici H, Bakkaloglu H, Aydin AE, Turkmen A, Nane I, Aydin F, Oguz FS.
    Transplant Proc; 2017 Apr 04; 49(3):425-429. PubMed ID: 28340805
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Caracterization of HLA allo-immunization and clinical impact in transfusion and organ transplantation].
    Delbos F, Cesbron A.
    Transfus Clin Biol; 2017 Sep 04; 24(3):131-137. PubMed ID: 28757117
    [Abstract] [Full Text] [Related]

  • 36. IVIG and HLA antibodies. Evidence for inhibition of complement activation but not for anti-idiotypic activity.
    Watanabe J, Scornik JC.
    Am J Transplant; 2005 Nov 04; 5(11):2786-90. PubMed ID: 16212641
    [Abstract] [Full Text] [Related]

  • 37. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P, Canbakan M, Kara M, Özel L, Ünal E, Titiz Mİ.
    Transplant Proc; 2012 Nov 04; 44(6):1652-5. PubMed ID: 22841237
    [Abstract] [Full Text] [Related]

  • 38. Behavior of the idiotypic network in conventional immune responses. I. Kinetics of idiotypic and anti-idiotypic antibodies following immunization with T-independent and T-dependent antigens.
    Schlueter AJ, Segre D, Kuhlenschmidt MS, Segre M.
    Cell Immunol; 1992 Oct 15; 144(2):311-23. PubMed ID: 1382868
    [Abstract] [Full Text] [Related]

  • 39. HLA antibodies present in the sera of sensitized patients awaiting renal transplant are also reactive to swine leukocyte antigens.
    Naziruddin B, Durriya S, Phelan D, Duffy BF, Olack B, Smith D, Howard T, Mohanakumar T.
    Transplantation; 1998 Oct 27; 66(8):1074-80. PubMed ID: 9808494
    [Abstract] [Full Text] [Related]

  • 40. Idiotypic regulation of the immune system. Common idiotypic specificities between idiotypes and antibodies raised against anti-idiotypic antibodies in rabbits.
    Winkler M, Franssen JD, Collignon C, Leo O, Mariamé B, van de Walle P, de Groote D, Urbain J.
    J Exp Med; 1979 Jul 01; 150(1):184-95. PubMed ID: 312906
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.